scorecardresearch
Follow Us:
Tuesday, June 02, 2020

Delhi: Plasma therapy to be used on trial basis to treat COVID-19 patients

The technique, also known as the convalescent plasma therapy, seeks to make use of the antibodies developed in the recovered patient against the coronavirus.

By: Express Web Desk | New Delhi | Updated: April 15, 2020 9:38:58 pm
coronavirus, coronavirus in ahmedabad, coronavirus cases in ahmedabad, coronavirus cases in Banaskantha, indian express news Last week, Kerala became the first state to receive ICMR approval for exploring the feasibility of convalescent plasma transfusion.

As Delhi’s coronavirus cases climbed to over 1,500, the state government on Wednesday announced that plasma enrichment technique would now be used to treat severely-ill COVID-19 patients on trial basis at a government hospital. Last week, Kerala became the first state to receive ICMR approval for exploring the feasibility of convalescent plasma transfusion.

Lt Governor Anil Baijal advised healthcare workers to strictly adhere to the guidelines and protocols issued by the Ministry of Health and Family Welfare while dealing with COVID-19 patients. “Delhi will use plasma technique for treatment on a trial basis to save lives of critical COVID-19 patients,” news agency ANI quoted him as saying.

Quoting an official, PTI stated that clinical trial of the plasma enrichment technique would be conducted at Institute of Liver & Biliary Sciences (ILBS).

The technique, also known as the convalescent plasma therapy, seeks to make use of the antibodies developed in the recovered patient against the coronavirus. The whole blood or plasma from such people is taken and then injected in critically ill patients so that the antibodies are transferred and boost their fight against the virus.

Follow Coronavirus LIVE news Updates

While the Indian Council of Medical Research (ICMR) is framing a protocol for the therapy, Kerala has received approval to go ahead with the trials.

“We are in the final stages of making a protocol for convalescent plasma therapy and after that we will need approval from the Drug Controller General of India… It will be done on a trial basis. Abroad, it has been found successful in limited trials. Here we will do it only on patients on ventilator or severe patients,” Dr Manoj Murhekar, Director, ICMR-National Institute of Epidemiology had said.

Convalescent plasma therapy banks on the age-old concept of passive immunity when antibodies for some diseases, such as diphtheria, were developed in horses and injected into humans. Active immunity is what is achieved by introducing an attenuated pathogen (such as the BCG vaccine) into the body to generate an immune response. The other kind of immunity is passive immunity.

On Wednesday, India crossed the 11,000-threshold of confirmed cases. The death toll due to the novel coronavirus rose to 392, while the number of cases saw a jump of 1,118 to go up to 11,933 cases, according to the Union Health Ministry.

(With inputs from agencies)

Don’t miss these articles on Coronavirus from the Explained section:

How coronavirus attacks, step by step

Mask or no mask? Why the guidance has been shifting

Besides a face cover, should I wear gloves when I go outdoors?

How the Agra, Bhilwara and Pathanamthitta Covid-19 containment models differ

Can coronavirus damage your brain?

📣 The Indian Express is now on Telegram. Click here to join our channel (@indianexpress) and stay updated with the latest headlines

For all the latest Delhi News, download Indian Express App.

Advertisement
Advertisement
Advertisement
Advertisement